All updated as on -
With a predicted CAGR of 9.8 percent from 2023–2031, the worldwide pediatric neurology device market is expected to increase from $2.28 billion in 2023 to $5.18 billion in 2031. Neurological disorders in neonates (newborns), babies, children, and adolescents are the focus of pediatric neurology, a subspecialty of general pediatric medicine. The causes, consequences, symptoms, and outcomes of neurological illnesses can range widely.
The main reason driving demand for pediatric neurology devices is the increasing number of neurological illnesses in children globally. Injuries, neurotoxins, illnesses, and genetics are among the many causes of the rising number of pediatric neurological problems, which can be either low- or high-risk. In children, seizures outnumber all other neurological disorders combined. It is necessary to use specialized neurological gadgets for the diagnosis and treatment of children since their brains work differently than those of fully grown adults. The creation of novel neurology devices is a direct outcome of the increased global investment in neurological research aimed at alleviating the burden of neurological diseases.
The future of the paediatric neurology device industry is predicted to be drastically altered by developments in healthcare technology, particularly the increasing use of machine learning and artificial intelligence. Sales of devices used in paediatric neurology are likely to rise as a result of increased public awareness of pediatric neurological illnesses brought about by new campaigns and programs launched by governments and public health organizations.
Due to the large number of neurological diseases affecting the target population, the diagnostic and biotechnology industries are projected to experience faster growth in the adoption of pediatric neurological devices. This presents an opportunity for the Pediatric Neurology Device Industry. There will be a favorable impact on the market expansion from the increased launch of new tests caused by advanced technology by various main companies worldwide. As an example, in February 2019, Medtronic plc made an announcement on the debut of Deep Brain Stimulation (DBS) in the United States for patients with medically refractory epilepsy. They also mentioned that Emory University in Atlanta, Georgia, had the first commercially implanted patient.
The anterior nucleus of the thalamus (ANT), a node in a network that plays a role in seizures, is the intended recipient of the regulated electrical pulses administered by deep brain stimulation (DBS) treatment for epilepsy. The rising incidence of neurological disorders, the rising frequency of pediatric neurological disease diagnoses, and the consequent surge in demand for pediatric neurological devices are all factors that are likely to propel the pediatric neurology devices market forward. This trend is especially true in developing nations.
Among the topics covered in this research on the pediatric neurology devices market are, trade regulations; import/export analyses; production optimization; value chain management; market share; the influence of local and national players in the market; opportunities for strategic market growth; changes in regulations pertaining to the market; market size; application niches and dominance; product approvals; product launches; geographic expansions; and technological innovations. For a more in-depth look at the pediatric neurology devices market, get in touch with us for an Analyst Brief. Our team is here to assist you in making a well-informed decision that will lead to progress in this market.
Because neurological disorders are so common and because many awareness campaigns have been launched all over the world, the general public's understanding of these conditions is quickly expanding to include individuals of all ages. The rising number of persons who pass away as a result of neurological illnesses is another factor driving sales of devices used in paediatric neurology. Patients with neurological diseases have a better chance of recovery and therapy if they are diagnosed early. People are being encouraged to act and seek treatment in the early stages of neurological diseases due to heightened awareness of how these diseases progress.
Due to the extensive usage of sophisticated neurological gadgets, which can be costly to acquire and run, the cost of treating a neurological ailment can certainly put a dent in anyone's budget these days. The high expense of treating patients is exacerbated by the fact that paediatric neurology equipment are expensive and have a restricted application because they are only meant for use with children.
Thanks to developments in healthcare IT and neurology research, the once-difficult task of diagnosing neurological disorders has become a massive potential for companies specializing in pediatric neurology devices. In order to make their products more accurate diagnostic tools, makers of pediatric neurology devices are concentrating on integrating cutting-edge technologies. Some important technologies that businesses can include to enhance the functionality of their devices include machine learning, enhanced medical imaging, and artificial intelligence.
Report Coverage
Global Pediatric Neurology Device research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Pediatric Neurology Device report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Pediatric Neurology Device competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Pediatric Neurology Device market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Pediatric Neurology Device market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Pediatric Neurology Device market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Boston Scientific Corporation, B.Braun Melsungen AG, Integra LifeSciences Corporation, St. Jude Medical, LLC, The Nemours Foundation, Inova Health System, Medtronic, Ethicon Inc., Elana, Inc., Abbott, Zimmer Biomet Holdings, Inc., Baxter International Inc., Co-Diagnostics, Inc., Russell Medical, Geisinger Health, Beaumont Health, Catholic Health Initiatives, Blue Sky Neurology, Allengers Medical Systems Limited, and ROIVANT SCIENCES LTD. among other
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Pediatric Neurology Device market based on the below-mentioned segments:
Global Pediatric Neurology Device Market, By Product Type
Neurostimulation Devices
Neurosurgery Devices
Cerebrospinal Fluid (CSF) Management Devices
Others
Global Pediatric Neurology Device market, By Age Group
Neonates
Infants
Children
Adolescents
Global Pediatric Neurology Device Market, By End User
Hospitals
Healthcare Centers
Neurological Research Centers
Global Pediatric Neurology Device market, Regional Analysis
The main reason driving demand for pediatric neurology devices is the increasing number of neurological illnesses in children globally. Injuries, neurotoxins, illnesses, and genetics are among the many causes of the rising number of pediatric neurological problems, which can be either low- or high-risk. In children, seizures outnumber all other neurological disorders combined. It is necessary to use specialized neurological gadgets for the diagnosis and treatment of children since their brains work differently than those of fully grown adults. The creation of novel neurology devices is a direct outcome of the increased global investment in neurological research aimed at alleviating the burden of neurological diseases.
The future of the paediatric neurology device industry is predicted to be drastically altered by developments in healthcare technology, particularly the increasing use of machine learning and artificial intelligence. Sales of devices used in paediatric neurology are likely to rise as a result of increased public awareness of pediatric neurological illnesses brought about by new campaigns and programs launched by governments and public health organizations.
Due to the large number of neurological diseases affecting the target population, the diagnostic and biotechnology industries are projected to experience faster growth in the adoption of pediatric neurological devices. This presents an opportunity for the Pediatric Neurology Device Industry. There will be a favorable impact on the market expansion from the increased launch of new tests caused by advanced technology by various main companies worldwide. As an example, in February 2019, Medtronic plc made an announcement on the debut of Deep Brain Stimulation (DBS) in the United States for patients with medically refractory epilepsy. They also mentioned that Emory University in Atlanta, Georgia, had the first commercially implanted patient.
The anterior nucleus of the thalamus (ANT), a node in a network that plays a role in seizures, is the intended recipient of the regulated electrical pulses administered by deep brain stimulation (DBS) treatment for epilepsy. The rising incidence of neurological disorders, the rising frequency of pediatric neurological disease diagnoses, and the consequent surge in demand for pediatric neurological devices are all factors that are likely to propel the pediatric neurology devices market forward. This trend is especially true in developing nations.
Among the topics covered in this research on the pediatric neurology devices market are, trade regulations; import/export analyses; production optimization; value chain management; market share; the influence of local and national players in the market; opportunities for strategic market growth; changes in regulations pertaining to the market; market size; application niches and dominance; product approvals; product launches; geographic expansions; and technological innovations. For a more in-depth look at the pediatric neurology devices market, get in touch with us for an Analyst Brief. Our team is here to assist you in making a well-informed decision that will lead to progress in this market.
Because neurological disorders are so common and because many awareness campaigns have been launched all over the world, the general public's understanding of these conditions is quickly expanding to include individuals of all ages. The rising number of persons who pass away as a result of neurological illnesses is another factor driving sales of devices used in paediatric neurology. Patients with neurological diseases have a better chance of recovery and therapy if they are diagnosed early. People are being encouraged to act and seek treatment in the early stages of neurological diseases due to heightened awareness of how these diseases progress.
Due to the extensive usage of sophisticated neurological gadgets, which can be costly to acquire and run, the cost of treating a neurological ailment can certainly put a dent in anyone's budget these days. The high expense of treating patients is exacerbated by the fact that paediatric neurology equipment are expensive and have a restricted application because they are only meant for use with children.
Thanks to developments in healthcare IT and neurology research, the once-difficult task of diagnosing neurological disorders has become a massive potential for companies specializing in pediatric neurology devices. In order to make their products more accurate diagnostic tools, makers of pediatric neurology devices are concentrating on integrating cutting-edge technologies. Some important technologies that businesses can include to enhance the functionality of their devices include machine learning, enhanced medical imaging, and artificial intelligence.
Report Coverage
Global Pediatric Neurology Device research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Pediatric Neurology Device report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Pediatric Neurology Device competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Pediatric Neurology Device market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Boston Scientific Corporation, B.Braun Melsungen AG, Integra LifeSciences Corporation, St. Jude Medical, LLC, The Nemours Foundation, Inova Health System, Medtronic, Ethicon Inc., Elana, Inc., Abbott, Zimmer Biomet Holdings, Inc., Baxter International Inc., Co-Diagnostics, Inc., Russell Medical, Geisinger Health, Beaumont Health, Catholic Health Initiatives, Blue Sky Neurology, Allengers Medical Systems Limited, and ROIVANT SCIENCES LTD. among other |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Pediatric Neurology Device Market from 2021 to 2031.
- Market Forecast for Pediatric Neurology Device Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Pediatric Neurology Device competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Pediatric Neurology Device
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Pediatric Neurology Device market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Pediatric Neurology Device market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Boston Scientific Corporation, B.Braun Melsungen AG, Integra LifeSciences Corporation, St. Jude Medical, LLC, The Nemours Foundation, Inova Health System, Medtronic, Ethicon Inc., Elana, Inc., Abbott, Zimmer Biomet Holdings, Inc., Baxter International Inc., Co-Diagnostics, Inc., Russell Medical, Geisinger Health, Beaumont Health, Catholic Health Initiatives, Blue Sky Neurology, Allengers Medical Systems Limited, and ROIVANT SCIENCES LTD. among other
Primary Target Market
- Market Players of Pediatric Neurology Device
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Pediatric Neurology Device market based on the below-mentioned segments:
Global Pediatric Neurology Device Market, By Product Type
Neurostimulation Devices
Neurosurgery Devices
Cerebrospinal Fluid (CSF) Management Devices
Others
Global Pediatric Neurology Device market, By Age Group
Neonates
Infants
Children
Adolescents
Global Pediatric Neurology Device Market, By End User
Hospitals
Healthcare Centers
Neurological Research Centers
Global Pediatric Neurology Device market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive pediatric neurology device market market research and competitor analysis for your business to help you develop more profound insights into the pediatric neurology device market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the pediatric neurology device market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.